Amed Tablet (Glymepiride)
Glimepiride 2mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.
MFDS item code 201404018 · Approved 2014.08.28
This product's status changed to Expired on 2024.08.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapies to help control blood glucose levels in patients with type 2 diabetes. It can be administered alone to improve blood glucose levels, and its effectiveness can be enhanced by combining it with other glucose-lowering agents or insulin if necessary. For instance, it is used in combination when managing blood glucose levels with oral hypoglycemic agents is difficult or when the control achieved with sulfonylureas or metformin monotherapy is insufficient. This medication effectively improves blood glucose control for patients.
The dose should be adjusted individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medicine should be taken into account. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly corrected by taking sugar. Hypoglycemia may recur even after it has initially been successfully treated during administration of a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical attention and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If a patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may be increased. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes or those with diabetic ketoacidosis or coma. Additionally, patients with allergies to this medication or sulfonylurea drugs, as well as those with severe liver or kidney dysfunction, should not use it. Women who are pregnant or breastfeeding are advised not to take this medication, and patients with severe infections, before and after surgery, or those who have suffered major trauma are recommended to switch to insulin treatment. Patients with gastrointestinal disturbances should be cautious as they may have issues absorbing food, increasing the risk of hypoglycemia. Patients with genetic lactose intolerance or lactase enzyme deficiency should also refrain from taking this medication. During the initial dosages, there is a high risk of hypoglycemia, so blood glucose levels must be monitored very carefully, especially in patients with poor nutritional status, irregular eating patterns, frequent alcohol consumers, those with impaired liver or kidney function, and the elderly. Symptoms of hypoglycemia can vary and may include headaches, severe hunger, nausea, fatigue, confusion, lowered consciousness, etc., so immediate consumption of sugar is necessary if symptoms occur. Serious side effects such as liver function abnormalities, blood abnormalities, and allergic reactions can occur very rarely, so patients should consult their doctor immediately if any unusual symptoms arise. During treatment with this medication, it is important to maintain a regular diet and exercise regimen, and to be prepared to consume sugar immediately in the event of hypoglycemia. If taken with other medications, it may affect blood glucose control, so all medications being taken should be disclosed to the doctor. In the case of pregnancy or breastfeeding, insulin treatment is preferred instead of this medication, and its safety and efficacy have not been verified in children under 18 years of age. Elderly patients may have reduced kidney function, so care must be taken in adjusting dosages. In cases of overdose, severe hypoglycemia may occur, so immediate hospital treatment should be sought for appropriate care.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorder, anxiety, aggression, decreased concentration, decreased agility or energy, depression, confusion, speech abnormalities, aphasia, visual disturbances, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina pectoris, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, anemia, granulocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, phototoxic skin reactions, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, indigestion, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.
Green oblong tablet
30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Glimepiride 2mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.